Fmr LLC Pacira Bio Sciences, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Fmr LLC holds 92,680 shares of PCRX stock, worth $2.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

92,680

Previous 146,160 36.59%

Holding current value

$2.06 Million

Previous $3.63 Million 39.01%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$22.91 - $27.14 $1.23 Million - $1.45 Million	-53,480 Reduced 36.59%	92,680 $2.22 Million
Q1 2025 May 12, 2025	BUY	$18.33 - $27.25 $1.22 Million - $1.82 Million	66,789 Added 84.15%	146,160 $3.63 Million
Q4 2024 Feb 13, 2025	BUY	$15.3 - $20.33 $186,751 - $248,147	12,206 Added 18.17%	79,371 $1.5 Million
Q3 2024 Nov 13, 2024	BUY	$11.7 - $28.46 $282,660 - $687,565	24,159 Added 56.18%	67,165 $1.01 Million
Q2 2024 Aug 13, 2024	BUY	$25.5 - $31.51 $22,006 - $27,193	863 Added 2.05%	43,006 $1.23 Million
Q1 2024 May 13, 2024	SELL	$27.7 - $35.48 $345,391 - $442,400	-12,469 Reduced 22.83%	42,143 $1.23 Million
Q4 2023 Feb 13, 2024	SELL	$26.32 - $34.31 $20,003 - $26,075	-760 Reduced 1.37%	54,612 $1.84 Million
Q3 2023 Nov 13, 2023	BUY	$30.68 - $40.09 $199,389 - $260,544	6,499 Added 13.3%	55,372 $1.7 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $47.5 $34,711 - $45,647	-961 Reduced 1.93%	48,873 $1.96 Million
Q1 2023 May 11, 2023	BUY	$35.53 - $43.38 $60,365 - $73,702	1,699 Added 3.53%	49,834 $2.03 Million
Q4 2022 Feb 13, 2023	SELL	$38.19 - $57.45 $41,588 - $62,563	-1,089 Reduced 2.21%	48,135 $1.86 Million
Q3 2022 Nov 10, 2022	BUY	$51.24 - $58.89 $24,646 - $28,326	481 Added 0.99%	49,224 $2.62 Million
Q2 2022 Aug 12, 2022	BUY	$51.49 - $81.64 $131,762 - $208,916	2,559 Added 5.54%	48,743 $2.84 Million
Q1 2022 May 13, 2022	BUY	$60.03 - $76.49 $2.75 Million - $3.51 Million	45,840 Added 13325.58%	46,184 $3.53 Million
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $13,335 - $17,294	278 Added 421.21%	344 $21,000
Q3 2021 Nov 15, 2021	BUY	$54.64 - $61.3 $218 - $245	4 Added 6.45%	66 $3,000
Q2 2021 Aug 13, 2021	BUY	$59.18 - $69.99 $3,669 - $4,339	62 New	62 $3,000

Others Institutions Holding PCRX

# of Institutions

258

Shares Held

51.2M

Call Options Held

289K

Put Options Held

130K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.02B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account